Charles Drew University/UCLA Cancer Center Partnership to Eliminate Cancer Health

查尔斯德鲁大学/加州大学洛杉矶分校癌症中心合作消除癌症健康

• 批准号: 7943137
• 负责人: Jaydutt V. Vadgama
• 金额: $ 190.31万
• 依托单位: CHARLES R. DREW UNIVERSITY OF MED & SCI
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-29 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7943137
• 关键词: African American; Age; Ambulatory Care; Area; Arts; Biological; Biological Markers; Breast Cancer Cell; California; Cancer Center; Cancer Patient; Cancer Research Project; Cancer cell line; Categories; Caucasians; Caucasoid Race; Characteristics; Charities; Chemopreventive Agent; Clinical; Clinical Research; Clinical Trials; Collection; Communities; Community Health; Community Outreach; Counseling; Data; Databases; Development; Diagnosis; Disadvantaged; Disease; Dominant-Negative Mutation; Economically Deprived Population; Education and Outreach; Environment; Epidemiology; Ethnic group; Faculty; Future; Genomics; Goals; Growth; Health; Health Status; Hispanics; Immunohistochemistry; Informatics; Integrins; Jonsson Comprehensive Cancer Center of University of California Los Angeles; Knowledge; Latina; Lead; Leadership; Learning; Los Angeles; Malignant Neoplasms; Mammary Gland Parenchyma; Measures; Medical Students; Medical center; Mentors; Mentorship; Minority; Minority Groups; Monoclonal Antibodies; Mus; NCI Scholars Program; National Cancer Institute; Outcome; Paraffin; Partner in relationship; Pathogenesis; Pathway interactions; Patients; Pilot Projects; Play; Population; Prevention strategy; Process; Prognostic Marker; Protein Binding; Proteins; RNA; Research; Research Infrastructure; Research Personnel; Research Training; Resistance; Resources; Role; Running; Sampling; Science; Services; Staining method; Stains; Techniques; Testing; Therapeutic; Tissue Microarray; Tissues; Training; Training Programs; Transgenic Animals; Transgenic Mice; Transgenic Organisms; Underserved Population; Universities; Validation; Work; anticancer research; biobank; cancer education; cancer health disparity; career; career development; chemotherapy; evidence base; experience; health disparity; human FRAP1 protein; in vivo; insight; malignant breast neoplasm; novel; novel therapeutic intervention; novel therapeutics; outcome forecast; outreach; overexpression; prognostic indicator; programs; receptor; research facility; response; socioeconomics; tissue resource; tumor progression

The proposed partnership between Charles Drew University (CDU) and UCLA Jonsson Cancer Center seeks to "Eliminate Cancer Health Disparities in Minority and Underserved Populations". This objective will continue to strengthen the CDU cancer research and training infrastructure by enhancing the participation of minority students, fellows and faculty engaged in Cancer Research, Training, and Cancer Outreach. The partnership will continue to recruit new faculty with career focus in cancer research, education or outreach. Likewise, UCLA and the investigators in the JCCC will have the important opportunity to address, issues related to the unequal burden of cancer in minority populations. The partnership developed during our U56 funding has made a significant impact on our ability to develop strong pilots and partnership programs. A key new and important addition to our U54 program is the development of strong Cancer Outreach Program and Projects. Thereby, we will train more minority investigators addressing issues in cancer research, education, training and outcome in our communities. In view of the rapidly changing demographics of Los Angeles and the state of California, the CDU-UCLA Partnership is ideally situated and will have an opportunity to have a positive impact on reducing cancer incidence and improving survival in minority and underserved populations. The overarching goals of the CDU-UCLA Cancer Partnership Program are to significantly increase the number of minority scientists in cancer research and to enhance the cancer outreach programs at CDU to address significant disparities in cancer among minority populations. Supported and implemented by an Administrative Core, Planning and Evaluation Core, and Developmental Core, the basic program components are 1) research projects; 2) the mentoring of students and junior investigators; 3) the training seminar series; 4) enhance CDU's integrated clinical and tissue biorepository data base on minority suubjects; 5) enhance community participation; 6) improve our clinical trials resource; and 7) increase faculty recruitment. We plan to submit 2 full projects and 2 pilot projects.

查尔斯·德鲁大学（CDU）和加州大学洛杉矶分校琼森癌症中心之间拟议的合作伙伴关系旨在“消除少数民族和服务不足人群的癌症健康差异”。这一目标将继续加强CDU癌症研究和培训基础设施，提高少数民族学生，研究员和教师参与癌症研究，培训和癌症外展。的 伙伴关系将继续招募新的教师与职业重点在癌症研究，教育或推广。 同样，加州大学洛杉矶分校和JCCC的研究人员将有重要的机会来解决与少数群体癌症负担不平等有关的问题。在U 56资助期间建立的合作伙伴关系对我们开发强大的试点和合作伙伴计划的能力产生了重大影响。一个关键的新的和重要的除了我们的U 54计划是强大的癌症外展计划和项目的发展。因此，我们将培训更多的少数民族研究人员，解决我们社区的癌症研究、教育、培训和结果问题。鉴于洛杉矶和加州州人口结构的迅速变化，CDU-UCLA伙伴关系处于理想位置，将有机会对减少癌症发病率和改善少数民族和服务不足人群的生存产生积极影响。 CDU-UCLA癌症合作计划的总体目标是显着增加癌症研究中少数民族科学家的数量，并加强CDU的癌症外展计划，以解决少数民族人群中癌症的显着差异。由行政核心，规划和评估核心和发展核心支持和实施，基本计划组成部分是1）研究项目; 2）学生和初级研究人员的指导; 3）培训研讨会系列; 4）加强CDU的少数民族综合临床和组织生物储存库数据库 5）加强社区参与; 6）改善我们的临床试验资源;和7）增加教师招聘。我们计划提交2个完整的项目和2个试点项目。